Printer Friendly

Wize Pharma reports one for-24 reverse common stock split.

M2 PHARMA-March 6, 2018-Wize Pharma reports one for-24 reverse common stock split

(C)2018 M2 COMMUNICATIONS

Biopharmaceutical company Wize Pharma Inc (OTCQB:WIZP) on Monday declared its one for-24 reverse split of its common stock with the opening of the market on 5 March 2018.

Under the reverse split, each 24 shares of issued and outstanding common stock will be converted into one share of common stock in the company.

The company said the reverse stock split will reduce the number of issued and outstanding common stock from approximately 104m to approximately 4.3m. The conversion price of its securities and the number shares of common stock issuable upon conversion will be split-adjusted.

According to the company, the split-adjusted common stock will trade under the ticker symbol WIZPD for 20 days, after which time the D will be removed and the stock will resume trading under the ticker symbol WIZP. The common stock post reverse split will have a new CUSIP number of 97751M 207.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Mar 6, 2018
Words:176
Previous Article:TeamHealth buys EmergiNet's clinical operations.
Next Article:Grifols to distribute its saline product in the US via Henry Schein.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters